Alicia Secor - 02 Dec 2025 Form 4 Insider Report for ZEVRA THERAPEUTICS, INC. (ZVRA)

Role
Director
Signature
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for Alicia Secor
Issuer symbol
ZVRA
Transactions as of
02 Dec 2025
Net transactions value
$0
Form type
4
Filing time
09 Dec 2025, 16:18:02 UTC
Previous filing
18 Sep 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Secor Alicia Director C/O ZEVRA THERAPEUTICS, INC., 1180 CELEBRATION BOULEVARD, SUITE 103, CELEBRATION /s/ Timothy J. Sangiovanni, Attorney-in-Fact for Alicia Secor 09 Dec 2025 0001584516

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZVRA Stock Option (right to buy) Award $0 +45,000 $0.000000 45,000 02 Dec 2025 Common Stock 45,000 $8.17 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, December 2, 2025.
F2 The option will vest and become exercisable as follows: (1) in three equal installments on the each of the dates that are one day prior to the first three annual stockholder meetings occurring after the grant date, or (2) immediately prior to a Change in Control, subject in each case to the director's continued service on such vesting date.